Sam Rasty, PhD, MBA
About Sam Rasty, PhD, MBA
Sam Rasty, PhD, MBA, serves as the Chief Executive Officer and Board Director at Sequence Bio, where he leads product development across various therapeutic areas. With extensive experience in the pharmaceutical industry, he has held leadership roles at notable companies such as GlaxoSmithKline, Shire, and Endo.
Current Role at Sequence Bio
Sam Rasty serves as the Chief Executive Officer and Board Director at Sequence Bio, a position he has held since 2023. In this role, he is responsible for overseeing the company's strategic direction and operational management. His leadership focuses on advancing product development across various therapeutic areas and technology platforms, including small molecules, biologics, and gene and cell therapies. Rasty's tenure at Sequence Bio is part of his broader commitment to enhancing precision medicine and genomics initiatives.
Education and Expertise
Sam Rasty holds a Ph.D. in Biochemistry from Louisiana State University, where he studied from 1984 to 1989. He also earned an MBA from Villanova University, completing his studies from 2000 to 2002. Additionally, Rasty completed a Postdoctoral Fellowship in Molecular Genetics, Virology, and Gene Therapy at the University of Pittsburgh School of Medicine from 1990 to 1996. His educational background supports his expertise in product development and precision medicine.
Professional Background
Rasty has extensive experience in the pharmaceutical industry. He worked at GlaxoSmithKline as Director of Portfolio Management for Global Commercial Strategy from 2004 to 2008. He then held the position of Director of Corporate Development at Endo for one year in 2010. Rasty served as Vice President and Head of New Products at Shire from 2011 to 2016. He also returned to Endo as Director of Strategic Marketing from 2008 to 2010. Additionally, he has been a Board Director at Oxford Biomedica since 2020.
Achievements in Disease Research
Rasty has contributed to uncovering novel signals of disease in the founder population of Newfoundland and Labrador, Canada. His work in this area highlights his commitment to advancing understanding in precision medicine and genomics. This expertise is integral to his leadership roles and strategic initiatives within the companies he has been associated with.
Leadership in Precision Medicine
Throughout his career, Sam Rasty has demonstrated a strong focus on leading initiatives in precision medicine and genomics. His strategic and operational leadership has been pivotal in developing innovative therapies across various platforms. Rasty's experience in these fields positions him as a key figure in advancing healthcare solutions tailored to individual patient needs.